Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose

Clinical trial NCT02017327 · COMPLETED

Trial details

NCT number: NCT02017327
Sponsor: Laboratoires Thea
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Open Angle Glaucoma Ocular Hypertension

Start date: 2013-12-01
Primary completion: 2016-07-01
Enrollment: 379

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.